FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
The company also received tentative approval for the 5mg, 10mg, 15mg, and 25mg strengths.
Hematologic Cancers
Trial to Compare Diets in Patients With Leukemia or MDS and Prolonged Neutropenia
The trial’s primary objective is to compare the incidence of major infections.
Phase 3 Trial Comparing Rituximab Biosimilar and Originator in Follicular Lymphoma
The primary outcome measure is overall response rate.
Younger Age at Diagnosis May Predict Higher VTE Risk in Patients With Multiple Myeloma
Researchers sought to determine whether higher-intensity thromboprophylaxis may be necessary for reducing the risk of VTE in younger patients with multiple myeloma.
Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
Risk of Cytokine Release Syndrome After CAR T-Cell Therapy May Vary by Ethnicity
Hispanic patients had significantly higher rates of severe cytokine release syndrome.
Salvage Autologous Stem Cell Transplantation May Improve Outcomes for Relapsed/Refractory Multiple Myeloma
Researchers sought to determine whether salvage therapy with high-dose chemotherapy followed by ASCT would improve survival in patients with MM.
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Patients With B-Cell Non-Hodgkin Lymphoma Treated With Anti-CD20 Antibodies Have Impaired Response to COVID-19 Vaccine
Researchers sought to determine whether patients with B-NHL who had treatment with anti-CD20 antibodies had an impaired serological response to an mRNA COVID-19 vaccine.
Poor Prognosis Seen for Patients With B-Cell Acute Lymphoblastic Leukemia Progression After CAR-T Therapy
Researchers sought to determine whether patients with B-ALL who progress after CAR-T therapy would have a poor prognosis.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...